9 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... and Dosing #Management ... Equianalgesics #Conversion ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Blocks - Nerve ... Distribution, Agents ... and Dosing Table ... #Medications #Doses ... #Dosing #Table
ACEI Antihypertensive Dose Comparison. Consider divided (BID) regimen for better pre-dose (trough) BP control for the
Antihypertensive Dose ... Comparison. ... for better pre-dose ... ACEInhibitor #ACEIs #Dosing ... #Conversion #Pharmacology
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... require phosphate binding ... agents since they ... Generally, the initial dose ... #Dosing #Pharmacology
Acute Pain Control In Patients On Medication Assisted Treatment (MAT)
Methadone - µ-opioid receptor agonist:
1) Continue maintenance
) Try increase dose ... or frequency of dosing ... or frequency of dosing ... naltrexone has high binding ... ) Try regional nerve
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... Agents to Treat ... and sodium • Dosing ... aspiration #Potassium #Binding ... pharmacology #table #comparison
Ultrasound (POCUS) For Nerve Blocks
Nerve block sites, agents, dosing and duration
Infographic by Dr. David Cisewski @dhcisewski
#Management
Blocks Nerve block ... sites, agents, ... dosing and duration ... #Anesthetics #Dosing ... #Doses #Table
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANTAGONIST (ARB) DOSING ... SWITCHING BETWEEN AGENTS ... an alternative agent ... Doses should be ... #Pharmacology #Conversion
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching between oral agents ... the timing and dosing ... Switching between oral agents ... Inhibitor #switching #conversion